Depressive Disorders - Northern Africa

  • Northern Africa
  • Revenue in the Depressive Disorders market is projected to reach US$259.20m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.69%, resulting in a market volume of US$277.20m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$17.49 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Northern Africa is experiencing significant growth and development. Customer preferences in the Depressive Disorders market in Northern Africa are shifting towards more holistic and natural treatment options. Customers are increasingly seeking alternative therapies such as herbal remedies, acupuncture, and meditation to manage their depressive symptoms. This preference for natural treatments is driven by a desire to avoid the potential side effects of pharmaceutical drugs and a growing awareness of the mind-body connection in mental health.Trends in the market indicate a rising demand for mental health services in Northern Africa. The stigma surrounding mental health is gradually diminishing, leading more individuals to seek professional help for their depressive disorders. This trend is further fueled by increased awareness campaigns and advocacy efforts that promote mental health and well-being.Local special circumstances in Northern Africa contribute to the development of the Depressive Disorders market. The region has a relatively high prevalence of depressive disorders due to various factors such as political instability, economic challenges, and social inequalities. These circumstances create a greater need for accessible and affordable mental health services, driving the growth of the market.Underlying macroeconomic factors also play a role in the development of the Depressive Disorders market in Northern Africa. Economic growth and urbanization have led to lifestyle changes, including increased stress levels and higher expectations, which can contribute to the development of depressive disorders. Additionally, improved healthcare infrastructure and increased government investment in mental health services have made treatment more accessible, further driving market growth.In conclusion, the Depressive Disorders market in Northern Africa is experiencing growth and development due to shifting customer preferences towards holistic treatments, increasing demand for mental health services, local special circumstances, and underlying macroeconomic factors. As awareness of mental health continues to grow and access to treatment improves, the market is expected to further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)